| Literature DB >> 31615278 |
Herbert Tilg1, Maria Effenberger1, Timon E Adolph1.
Abstract
Entities:
Keywords: Canakinumab; diabetes; drug therapy; metabolic inflammation; nonalcoholic fatty liver disease
Mesh:
Substances:
Year: 2019 PMID: 31615278 DOI: 10.1080/13543784.2020.1681397
Source DB: PubMed Journal: Expert Opin Investig Drugs ISSN: 1354-3784 Impact factor: 6.206